SCHEMBL2401918

SCHEMBL2401918

C=CCN(C)C=CC=C(C(=O)OC)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 1/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ ALDH1A1 P00352 4/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NOD2 Q9HC29 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401914 1.00 C5AR1 (0.38) C5AR1NPSR1SMN1; SMN2TDP1ALDH1A1
SCHEMBL2399698 0.90 RAB9A (0.43) SMN1; SMN2ALDH1A1KMT2ARAB9AMEN1
SCHEMBL2399700 0.90 RAB9A (0.43) SMN1; SMN2ALDH1A1KMT2ARAB9AMEN1
SCHEMBL12268345 0.77 LMNA (0.32) NPSR1SMN1; SMN2LMNAHTTMAPT
SCHEMBL4620452 0.77 ALDH1A1 (0.39) C5AR1SMN1; SMN2ALDH1A1KMT2ARAB9A
SCHEMBL13609928 0.76 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1KMT2ARAB9AMEN1
SCHEMBL4544753 0.76 ALDH1A1 (0.39) NPSR1SMN1; SMN2TDP1ALDH1A1KMT2A
SCHEMBL12268367 0.74 — —
SCHEMBL13609923 0.73 ALDH1A1 (0.48) SMN1; SMN2TDP1ALDH1A1KMT2ARAB9A
SCHEMBL805450 0.73 ALDH1A1 (0.48) SMN1; SMN2TDP1ALDH1A1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8025867-B2 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds L'OREAL (FR) 2011-09-27 — — US disclosed
EP-1885730-B1 SILANE MEROCYANINE SULPHONE DERIVATIVES; PHOTOPROTECTING COMPOSITIONS CONTAINING SAME; USE THEREOF AS UV FILTER OREAL (FR) 2009-04-22 — — EP disclosed
US-7510703-B2 UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones L'OREAL (FR) 2009-03-31 — — US disclosed
US-20080305058-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds L'OREAL (FR) 2008-12-11 — — US disclosed
EP-1885730-A1 SILANE MEROCYANINE SULPHONE DERIVATIVES; PHOTOPROTECTING COMPOSITIONS CONTAINING SAME; USE THEREOF AS UV FILTER L'OREAL (FR) 2008-02-13 — — EP disclosed
US-20070224147-A1 UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones L'OREAL (FR) 2007-09-27 — — US disclosed
WO-2006032741-A1 SILANE MEROCYANINE SULPHONE DERIVATIVES; PHOTOPROTECTING COMPOSITIONS CONTAINING SAME; USE THEREOF AS UV FILTER L'ORÉAL (FR) 2006-03-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070224147-A1 UV-photoprotecting/sunscreen compositions comprising silane/siloxane derivatives of merocyanine sulfones ERCC1, ERCC5, CRY1 C5AR1 4119/4885NPSR1 3128/4885SMN1; SMN2 2736/4885
US-20080305058-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds DDT, DSG1, DSC1 C5AR1 4561/4885NPSR1 4074/4885SMN1; SMN2 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback